Time to see who blinks first on PDUFA

Washington

WASHINGTON - Reauthorization of the Prescription Drug User Fee Act and FDA reform legislation (S. 830) will be near the top of a very full agenda when the Senate resumes its work this week. But the Senators will be asked to vote on a revised version of S. 830 that many of them still have not seen, and the prospect of last-minute roadblocks erected by Sen. Edward Kennedy continues to haunt efforts to link reform provisions with PDUFA, which exipires at the end of the month...